News and Events

News

All categories

Earnings

Press Release

All years

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019

June 24, 2019

Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland

June 12, 2019

Affimed Announces Annual General Meeting of Shareholders

June 4, 2019

Affimed to Present at the Jefferies 2019 Healthcare Conference

May 29, 2019

Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress

May 22, 2019

Affimed Announces First Quarter 2019 Financial Results and Corporate Update Conference Call on May 22, 2019

May 16, 2019

Affimed Provides Regulatory Update on AFM11 Clinical Program

April 17, 2019

Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting

April 1, 2019

Affimed Reports 2018 Financial Results and Operational Progress

March 27, 2019

Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019

March 20, 2019

Events

All

Scientific

Investors

There are no events planned at the moment.

Webcasts More events

News and Events

News and Events

See what’s new at Affimed

See what’s new at Affimed

News

Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019

Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland

Affimed Announces Annual General Meeting of Shareholders

Affimed to Present at the Jefferies 2019 Healthcare Conference

Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress

Affimed Announces First Quarter 2019 Financial Results and Corporate Update Conference Call on May 22, 2019

Affimed Provides Regulatory Update on AFM11 Clinical Program

Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting

Affimed Reports 2018 Financial Results and Operational Progress

Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019

Events